| Application no. and date | 18724690.5 (espacenet) (Federated) (European Patent Register), 20180427 | | Patent/reg. no. and date | DK/EP 3615066, 20231227 | | Publication date | 20200304 | | Priority no. and date | US 201762492056 P, 20170428 | | EP pub. no. and date |
EP 3615066 20200304 | | Effective date | | | Applicant/owner | Amgen Inc., One Amgen Center Drive
Thousand Oaks, California 91320-1799, US | | Applicant ref. no. | 1695725 | | Inventor | BRYCH, Stephen, Robert, 2488 Gillingham Circle
Thousand Oaks, CA 91362, US,
WONG, Lyanne, M., 28861 Silversmith Drive
Valencia, CA 91354, US,
FALLON, Jaymille, 28915 Thousand Oaks Blvd, 187
Agoura Hills, CA 91301, US,
GOSS, Monica, Michelle, 3050 Lodgewood Street
Newbury Park, CA 91320, US,
GU, Jian, Hua, 1525 Silver Shadow Drive
Thousand Oaks, CA 91320, US,
GHATTYVENKATAKRISHNA, Pavan, K., 285 Third Street N121
Cambridge, MA 02142, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/28 (2006.01) | | Title | FORMULERINGER AF HUMANE ANTI-RANKL-ANTISTOFFER OG FREMGANGSMÅDER TIL ANVENDELSE DERAF | | Int. application no. | US2018029728 | | Int. publication no. | WO2018200918 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
